SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron
AVIR 3.490+3.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brad C. Dunlap who wrote (104)8/4/1997 7:48:00 AM
From: David   of 645
 
Brad, you are right that>>> This analysis has gotten to levels lower
then my niece's report that her sixth grade class presented on the stock market<<. There are too many contraditions in your statements, the market size, 1.18 billion or 300 million; the release date of H&Q recommondation; if such release is against the NADSQ rule or not; and we will see whether the officers of AVIR are involved in the insiders selling. However, that superised me is that how could such words >>>irritate the hell out of me with bullshit<<< come out the post of such famous expert like you????? Personal attack does no good for you.

Please read the recommondation of H&Q of last Dec. fast.quote.com{rgmijvsceket
>>>Other projects (of AVIR)include a flu vaccine for the elderly<<<. I belive it says that the flu vaccine in phase III trial can't used for old people. Otherwise, AVIR don't need to spend extral money in such project. Therefore, the potential market size for the flu vaccine is even smaller.

I am interesting to read the 144 filings of AVIR, which you promise to post it today.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext